Symbiosis Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Early Stage VC
- Investors
-
31
Symbiosis General Information
Description
Developer of a decentralized multi-chain protocol designed to provide liquidity. The company's technology allows users to swap tokens with a single click between all the chains while remaining the sole owners of the funds and simplifying the time-consuming process of finding a suitable cross-chain bridge, enabling users to eliminate the need to hold different native assets.
Contact Information
Website
www.symbiosis.financeCorporate Office
- Presnenskaya Naberezhnaya Tenancy 10
- Marina House, Mahe
- Eden Island, 9F5G98W
- Seychelles
Corporate Office
- Presnenskaya Naberezhnaya Tenancy 10
- Marina House, Mahe
- Eden Island, 9F5G98W
- Seychelles
Symbiosis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC | 19-Feb-2022 | Completed | Generating Revenue | |||
| 1. Seed Round | 01-Dec-2021 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Symbiosis Comparisons
Industry
Financing
Details
Symbiosis Competitors (2)
One of Symbiosis’s 2 competitors is DeBridge, a Venture Capital-Backed company based in Hong Kong, Hong Kong.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| DeBridge | Venture Capital-Backed | Hong Kong, Hong Kong | ||||
| Synapse Network | Venture Capital-Backed | London, United Kingdom |
Symbiosis Signals
Symbiosis Investors (31)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Bitgert Ventures | Corporate Venture Capital | Minority | ||
| Delta Blockchain Fund | Venture Capital | Minority | ||
| Drops Ventures | Venture Capital | Minority | ||
| Hack VC | Venture Capital | Minority | ||
| Horadrim Capital | Venture Capital | Minority |
Symbiosis Investments (3)
Symbiosis’s most recent deal was a Later Stage VC with Fore Biotherapeutics for . The deal was made on 08-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Fore Biotherapeutics | 08-Jul-2026 | Later Stage VC | Drug Discovery | ||
| CORXEL Pharmaceuticals | 22-Jan-2026 | Later Stage VC | Drug Discovery | ||
| SanegeneBio | 20-Nov-2025 | Early Stage VC | Drug Discovery |
Symbiosis FAQs
-
When was Symbiosis founded?
Symbiosis was founded in 2021.
-
Where is Symbiosis headquartered?
Symbiosis is headquartered in Eden Island, Seychelles.
-
What is the size of Symbiosis?
Symbiosis has 16 total employees.
-
What industry is Symbiosis in?
Symbiosis’s primary industry is Brokerage.
-
Is Symbiosis a private or public company?
Symbiosis is a Private company.
-
What is Symbiosis’s current revenue?
The current revenue for Symbiosis is .
-
How much funding has Symbiosis raised over time?
Symbiosis has raised $10M.
-
Who are Symbiosis’s investors?
Bitgert Ventures, Delta Blockchain Fund, Drops Ventures, Hack VC, and Horadrim Capital are 5 of 31 investors who have invested in Symbiosis.
-
Who are Symbiosis’s competitors?
DeBridge and Synapse Network are competitors of Symbiosis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process